Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,138,070
-
Share change
-
+558,864
-
Total reported value
-
$2,134,233,294
-
Put/Call ratio
-
157%
-
Price per share
-
$64.41
-
Number of holders
-
224
-
Value change
-
+$34,270,176
-
Number of buys
-
125
-
Number of sells
-
92
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q4 2018
As of 31 Dec 2018,
GENOMIC HEALTH INC - COM (GHDX) was held by
224 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,138,070 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Vanguard Group Inc, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, FMR LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
224
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.